In the large intestine HT-29 cell lines, EGCG increased the activity of TfR (transferrin receptor), which is a carrier protein for transferrin, and inhibited the activity of the ferritin-H protein through iron chelating activity in HT-29 colon cancer cells [94]. The gene discussed is TFRC; the disease is colonic neoplasm.